Side-firing fiber delivery device with active cooling cap

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Boston Scientific Scimed, Inc. patent solves the following problem:

Medical laser used in the method of treatment that involves various areas of practice, including, for example, urology, neurology, otorhinolaryngology, general anesthetic in eye, dentistry, gastroenterology, cardiology, gynecology, and thoracic and orthopedic procedures. Usually, these methods require precisely controlled delivery of laser energy, and often the places where the laser energy delivered is located deep within the body; for example, the prostate or the Fallopian tube. Because of the location of the target tissues deep within the body, the medical procedure requires that the optical fiber that is flexible and maneuver. Various sources of light can be used with optical fiber devices dependent upon the need for light source; for example, pulsed laser, diode laser and neodymium laser can be used as a light source. Representative laser used in medical treatment methods include Ho: YAG laser and Nd: YAG laser.

Our analysis of this patent is as follows:

Boston Scientific Scimed, Inc.’s patent US 9456871 B2 deals with Side-firing fiber delivery device with active cooling cap.
An optical fiber includes an internal fiber, an end face, a first cap member and a second member of the cap. The internal fiber ends of a fiber tip. The end face pass laser energy delivered through the internal fiber. The first member of the cap has on the face at the end and includes a first end of a first side of the face end and a second end of a second side of the face end. The second member of the cap provided on the first of the cap and includes a first end of the first side of the face end and a second end of the second side of the face, the second end of the second member of the cap is attached to the second end of the first members of the cap.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Apparatus for use with needle insertion guidance system

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The C. R. Bard, Inc. patent solves the following problem:

Our analysis of this patent is as follows:

C. R. Bard, Inc.’s patent US 9456766 B2 deals with Apparatus for use with needle insertion guidance system.
A guidance system for assisting the insertion of a needle into a patient's body revealed. The guidance system uses ultrasound imaging or other appropriate imaging technologies. In one embodiment, the guidance system consists of an imaging device including an investigation to bring to an image of an internal body part target, like a vessel. One or more sensor included in the investigation. The sensor can feel a noticeable traits associated with needle, such as a magnetic field of a magnet that includes needle. The system includes a processor that uses data relating to the natural feel to determine a 3-D position of the needle. The system includes a display for describing the position of the needle. needle may include a donut-shaped magnet disposed of the needle cannula, or a removable stylet with a magnetic element and a strain gauge for the detection of the needle distal tip.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Methods and products to provide oral nutritional care to subjects with dementia

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The D&E; Gillespie Enterpries LLC patent solves the following problem:

Dementia is a group of disorders characterized by the loss of integrated central nervous system functions, resulting in a diminished ability to understand concepts or instructions, store and retrieve information to memory, and in behavior and personality changes.

Our analysis of this patent is as follows:

D&E; Gillespie Enterpries LLC’s patent US 9456628 B2 deals with Methods and products to provide oral nutritional care to subjects with dementia.
The present invention provides food products, nutritional programs, and procedures for meeting the nutritional needs of those with dementia and related mental disorder. In one embodiment, the invention provides a food product comprising a reversibly sealed vessel and a broth, the broth in the container and consists of a total number 200-2000 MLS, a vegetable or meat component, 300 to 2500 calories, a macronutrient caloric distribution comprising: 20-80% fat, 10-45% protein, and 10-65% carbohydrate, 2 % to about 40% medium chain triglyceride, omega 3 fatty acids in an amount of 100 to 2000 mg and less than 20 strong food particles that have a mass greater than 20 cm3. The food product, when administered to the affected subjects, positive effect (i) nutritional status; (Ii) the quality of life; (Iii) disease course; (B) the need for help from a care giver; (Vi) subject carrying out a nutritional plan to use in food products, and (viii) ease of monitoring compliance with caretaker for verification.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The The Brigham And Women’s Hospital, Inc., , Beth Israel Deaconess Medical Center, Inc. patent solves the following problem:

Staphylococci programs-positive bacteria normally inhabit and colonize the skin and mucus membranes of humans. If the skin or mucus membranes can be damaged during surgery or other trauma, the staphylococci to gain access to internal tissues causing infection to develop. When the staphylococci proliferate locally or enter the lymphatic or blood system, serious infectious complications associated with staphylococcal bacteremia may result. Complications associated with Staphylococcal bacteremia include septic shock, endocarditis, arthritis, osteomyelitis, pneumonia, and abscesses in various organs.

Our analysis of this patent is as follows:

The Brigham And Women’s Hospital, Inc., , Beth Israel Deaconess Medical Center, Inc.’s patent US 9458227 B2 deals with Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof.
The present invention relates to peptide, particularly human monoclonal antibody, which are particularly poly-N-acetyl glucosamine (pnag), as Staphylococcal pnag, acetylated, partially acetylated and / or fully deacetylated form. The invention further provides methods of using these peptides in the diagnosis, Branch Tomato and therapy of bacterial expression pnag such as but not limited to staphylococci and E. coli. The other antibody formulation development opsonophagocytic murder and in vivo protection against bacteria expressing pnag such as but not limited to staphylococci and E. coli. Composition of these peptides, including pharmaceutical compositions, which also, as functionally equivalent variants of the peptide.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Recombinant antibodies against H1N1 influenza

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Emory University, , The University Of Chicago patent solves the following problem:

The swine H1N1 influenza virus now causing a global pandemic associated with substantial morbidity and mortality1-5. This newly emergent strain is immunologically different from other influenza viruses including the new H1N1 strains6 thus leaving a large population of the world are very susceptible to infection of pandemic virus7. Although there are some B cell cross-reactivity with seasonal influenza virus protective epitopes swine H1N1 virus so that race.

Our analysis of this patent is as follows:

Emory University, , The University Of Chicago’s patent US 9458226 B2 deals with Recombinant antibodies against H1N1 influenza.
Antibodies that bind with high affinity to the swine H1N1 virus described. In vivo experiments showed that the antibody could completely protect the mice were challenged with a lethal dose of the swine H1N1 virus. antibody is able to cure mice in a therapeutic situation when treated as late as 60 hours (2.5 days) after the infection with swine H1N1 virus. Also described the artificial kind of antibody.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Control of caloric intake

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Seth D. Roberts patent solves the following problem:

Many procedures described in point resulting in a loss in weight in men, especially in the loss of body fat. However, the data supporting these claims quickly and safely lose large amounts of weight are suspects in many cases, if it even exists. The way the data published, five well known:

Our analysis of this patent is as follows:

Seth D. Roberts’s patent US 9456619 B1 deals with Control of caloric intake.
A method for reducing the human or animal weight from body fat, which consists of giving a caloric source with a mild flavor or less flavor, other than sweet season, a time when race at mealtime and in an amount sufficient to provide a significant part of the total daily caloric consumption, while eating the normal diet of meat.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Recognizing a movement of a pointing device

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Microsoft Technology Licensing, Llc patent solves the following problem:

Increasing our environment inhabited by a multitude of intelligent devices, each specialist function. The modern living room, for example, often appeared on a television, amplifier, DVD player, lights, and so on. In the near future, we look forward to these devices become more inter-connected, more and more specialists as part of a more complex and powerful integrated intelligent environment. It shows in a challenge to design a good user interface.

Our analysis of this patent is as follows:

Microsoft Technology Licensing, Llc’s patent US 9454244 B2 deals with Recognizing a movement of a pointing device.
The present invention is directed to a system and process that controls a group of networked electronic components using a multimodal integration scheme that inputs from one speech recognition portion of the system, actions to their role in the system using a wireless pointing device and teaching analysis of the systems also use the pointing device, that combined to determine what component of a user who wants to control and what control actions desired. In this multimodal integration scheme, the desired action of an electronic component decomposed into a command and a referent. referent can be identified using the pointing device to recognize the teaching component by component or something associated with it, through the use of speech recognition, or both. commands can be specified by pressing a button on the pointing device, by an action taken by the pointing device, through an event that speech recognition, or any combination thereof these inputs.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Displaying and inserting handwriting words over existing typeset

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Lenovo (Singapore) Pte. Ltd. patent solves the following problem:

Information management device (device), for example cell phone, Smart phone, tablet, laptop computers, and the like to permit users to input text using a finger or a pen / stylus. It allows users to write more naturally and without the use of a keyboard.

Our analysis of this patent is as follows:

Lenovo (Singapore) Pte. Ltd.’s patent US 9454694 B2 deals with Displaying and inserting handwriting words over existing typeset.
A photo provides a method, including: receiving an input overlay applications, one or more ink strokes given to an input side of the field covered; where the input field overlay area located on an underlying display applications; and to provide, in the area input field overlay, an at least partially opaque background. Other embodiments are described and claimed.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Recombinant Lactococcus lactis expressing Escherichia coli colonization factor antigen I (CFA/I) fimbriae and their methods of use

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Montana State University patent solves the following problem:

Target immunotherapy is a great way to treat chronic infections, autoimmune diseases, allograft rejection, and malignancies. Immunotherapy with autoimmune disorder also especially attractive for the correction of inflammatory diseases without having to resort to immunosuppressive drug therapy. (Kochetkova, 2008).

Our analysis of this patent is as follows:

Montana State University’s patent US 9452205 B2 deals with Recombinant Lactococcus lactis expressing Escherichia coli colonization factor antigen I (CFA/I) fimbriae and their methods of use.
The present disclosure relates generally to therapeutic compositions containing artificial bacteria. Moreover, the disclosure of details on the methods of using the teaching of therapeutic compositions to treat autoimmune and inflammatory diseases. The present teachings also relate to express artificial bacteria and methods of producing the artificial bacteria used in the compositions and methods. Also appointed in dietary supplements and food additive composition comprising the teaching on artificial bacteria.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Skin abrader

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Irhythm Technologies, Inc. patent solves the following problem:

This application describes embodiments of machinery, methods, and systems for the abrasion of the skin to prepare for use in an electrode for the detection of cardiac and other low-electrical signal generated within the human body, allowing for increased short-term and long-term adhesion and better conductance through the skin, resulting in a better quality signal recorded data.

Our analysis of this patent is as follows:

Irhythm Technologies, Inc.’s patent US 9451975 B2 deals with Skin abrader.
The present invention relates to devices, methods, and systems for abrading the skin to prepare for the attachment of an electrode. In some embodiments, the invention to provide for a simple, inexpensive device 120 with a flat, abrading surface that removes the top layer of the skin without causing excessive damage.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.